WaveDyn
Designing wavefront guided scleral lenses for EyePrintPRO, Europa, and Zenlens.
Principal InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
The clinical studies our optometrists take part in, and the ones we have helped complete. Our focus is scleral lenses, myopia control, and corneal care.
Featured study
A study for children that looks at whether a type of eyeglass lens called DG1 can help slow the progression of myopia (nearsightedness).
Learn more and sign upStudies our doctors are taking part in right now.
Designing wavefront guided scleral lenses for EyePrintPRO, Europa, and Zenlens.
Principal InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
Using front surface eccentricity to manage higher order aberrations for scleral lens wearers.
Principal InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
A look back at the research our doctors have contributed to.
Data collection across multiple centers on real world scleral lens outcomes.
Provider ScientistDr. Nathan Schramm, OD, FSLS, FBCLA
A randomized clinical trial on orthokeratology lenses for myopia control.
Co-InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA, with Dr. Ariel Chen, OD
Looking at a high oxygen scleral lens material for the signs and symptoms of dry eye disease.
Co-InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
The first genetic test to help determine the risk of keratoconus. Our team collected patient DNA toward Avellino's AvaGen approval.
Co-InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
A case-control study with Nova Southeastern University on the risks of soft contact lenses in adolescents and teens.
Co-InvestigatorDr. Nathan Schramm, OD, FSLS, FBCLA
A quick look at the areas our optometrists have helped move forward, without the deep dive.
Focus areas
Custom lenses for irregular eyes.
Clearer vision beyond standard correction.
Slowing nearsightedness in children.
Understanding who is at risk.
Safer lens wear for younger patients.
Comfort for the front of the eye.
Interested in taking part? The KIND study is open for sign-up. Learn more and sign up →
